Cognition in schizophrenia: a marker of underlying neurodevelopmental problems?-Reference-Cited by-同舟云学术

Cognition in schizophrenia: a marker of underlying neurodevelopmental problems?

Published:2019-05-06 Issue:2 Volume:18 Page:164-165
ISSN:1723-8617
Container-title:World Psychiatry
language:en
Short-container-title:World Psychiatry

Author:

Melle Ingrid¹

Affiliation:

1. NORMENT Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway

Publisher

Wiley

Subject

Psychiatry and Mental health,Phychiatric Mental Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/wps.20646

Reference10 articles.

1. Nonsocial and social cognition in schizophrenia: current evidence and future directions

2. Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence

3. Assessment of Cognition and Personality as Potential Endophenotypes in the Western Australian Family Study of Schizophrenia

4. Observed Cognitive Performance and Deviation From Familial Cognitive Aptitude at Age 16 Years and Ages 18 to 20 Years and Risk for Schizophrenia and Bipolar Illness in a Swedish National Sample

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Goal Management Training on self-efficacy, self-esteem, and quality of life for persons with schizophrenia spectrum disorders;Frontiers in Psychology;2024-03-07

2. Evolving Concepts for the Assessment and Treatment of Schizophrenia;Mental Health Research and Practice;2024-01-31

3. Vocal emotion perception in schizophrenia and its diagnostic significance;BMC Psychiatry;2023-10-17

4. Smartphone video games improve cognitive function in patients with chronic schizophrenia: a randomized controlled trial;European Archives of Psychiatry and Clinical Neuroscience;2023-08-18

5. Clinical and developmental characteristics of cognitive subgroups in a transdiagnostic sample of schizophrenia spectrum disorders and bipolar disorder;European Neuropsychopharmacology;2023-03